.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Healthtrust
Chinese Patent Office
Dow
Mallinckrodt
McKinsey
Merck
Cipla
Deloitte

Generated: June 26, 2017

DrugPatentWatch Database Preview

Mebendazole - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for mebendazole and what is the scope of mebendazole patent protection?

Mebendazole
is the generic ingredient in two branded drugs marketed by Amedra Pharms Llc and Janssen Pharms, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for mebendazole. Four suppliers are listed for this compound.

Summary for Generic Name: mebendazole

Tradenames:2
Patents:1
Applicants:2
NDAs:3
Drug Master File Entries: see list6
Suppliers / Packagers: see list4
Bulk Api Vendors: see list81
Clinical Trials: see list17
Patent Applications: see list3,232
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mebendazole at DailyMed

Pharmacology for Ingredient: mebendazole

Drug ClassAntihelminthic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms
VERMOX
mebendazole
TABLET, CHEWABLE;ORAL208398-001Oct 19, 2016RXYesYes► Subscribe► Subscribe
Amedra Pharms Llc
EMVERM
mebendazole
TABLET, CHEWABLE;ORAL073580-001Jan 4, 1995RXNoYes► Subscribe► Subscribe
Janssen Pharms
VERMOX
mebendazole
TABLET, CHEWABLE;ORAL017481-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: mebendazole

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
VERMOX
mebendazole
TABLET, CHEWABLE;ORAL017481-001Approved Prior to Jan 1, 19823,657,267► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Cipla
Julphar
Medtronic
Harvard Business School
Novartis
McKinsey
Baxter
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot